Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $39.00

Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) have earned an average recommendation of “Moderate Buy” from the five brokerages that are presently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year target […]

Related Keywords

Illinois , United States , Los Angeles , California , Piper Sandler , Scott Dreyer , Illinois Municipal Retirement Fund , Securities Exchange Commission , Los Angeles Capital Management , Collegium Pharmaceutical Inc , Nasdaq , Maverick Capital Ltd , Tower Group , Needham Company , Summerhaven Investment Management , Collegium Pharmaceutical Company Profile , Jefferies Financial Group , Collegium Pharmaceutical , Get Free Report , Marketbeat Ratings , Financial Group , Truist Financial , Exchange Commission , Haven Investment Management , Municipal Retirement Fund , Angeles Capital Management , Get Free , Collegium Pharmaceutical Daily , Nasdaq Coll , Coll , Medical , Ratings , Consensus ,